{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:51:31Z","timestamp":1790250691060,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00198-016-3802-5","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T10:35:44Z","timestamp":1476959744000},"page":"945-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Increased levels of Dickkopf-1 are indicative of Wnt\/\u03b2-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7803-5794","authenticated-orcid":false,"given":"C.","family":"Tsentidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gourgiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kossiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marmarinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Doulgeraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Karavanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"3802_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2007.10.008","volume":"34","author":"A Rakel","year":"2008","unstructured":"Rakel A, Sheehy O, Rahme E, LeLorier J (2008) Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 34:193\u2013205","journal-title":"Diabetes Metab"},{"key":"3802_CR2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:427\u2013444","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"3802_CR3","doi-asserted-by":"crossref","first-page":"174186","DOI":"10.1155\/2015\/174186","volume":"2015","author":"T Khan","year":"2015","unstructured":"Khan T, Fraser L (2015) Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype. J Osteoporos 2015:174186","journal-title":"J Osteoporos"},{"key":"3802_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2013.00021","volume":"4","author":"J Starup-Linde","year":"2013","unstructured":"Starup-Linde J (2013) Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol 4:21","journal-title":"Front Endocrinol"},{"key":"3802_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4239\/wjd.v4.i4.101","volume":"4","author":"B Roy","year":"2013","unstructured":"Roy B (2013) Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures. World J Diabetes 4:101\u2013113","journal-title":"World J Diabetes"},{"key":"3802_CR6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.14310\/horm.2002.1111024","volume":"6","author":"MP Yavropoulou","year":"2007","unstructured":"Yavropoulou MP, Yovos JG (2007) The role of the wnt signaling pathway in osteoblast commitment and differentiation. Hormones 6:279\u2013294","journal-title":"Hormones"},{"key":"3802_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00774-007-0824-2","volume":"26","author":"R Nishimura","year":"2008","unstructured":"Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T, Wada M, Amano K, Yoneda T (2008) Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab 26:203\u2013212","journal-title":"J Bone Miner Metab"},{"key":"3802_CR8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, MacDougald OA (2006) Regulation of bone mass by wnt signaling. J Clin Invest 116:1202\u20131209","journal-title":"J Clin Invest"},{"key":"3802_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2007.05.009","volume":"41","author":"B MacDonald","year":"2007","unstructured":"MacDonald B, Joiner D, Oyserman S, Sharma P, Goldstein S, He X, PV. H (2007) Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41:331\u2013339","journal-title":"Bone"},{"key":"3802_CR10","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/emboj\/21.5.966","volume":"21","author":"L Grotewold","year":"2002","unstructured":"Grotewold L, Ruther U (2002) THe wnt antagonist dickkopf-1 is regulated by bmp signaling and c-Jun and modulates programmed cell death. EMBO J 21:966\u2013975","journal-title":"EMBO J"},{"key":"3802_CR11","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","volume":"4","author":"HY Choi","year":"2009","unstructured":"Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930","journal-title":"PLoS One"},{"key":"3802_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","volume":"82","author":"W Balemans","year":"2008","unstructured":"Balemans W, Piters E, Cleiren E, m A, Van Wesenbeeck L, Warman M, Van Hul W (2008) The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone nass LRP5. Calcif Tissue Int 82:445\u2013453","journal-title":"Calcif Tissue Int"},{"key":"3802_CR13","doi-asserted-by":"crossref","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, Lengner CJ, Hovhannisyan H et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 Gene expression. J Biol Chem 280:33132\u201333140","journal-title":"J Biol Chem"},{"key":"3802_CR14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/en.2007-1408","volume":"149","author":"J Fowlkes","year":"2008","unstructured":"Fowlkes J, Bunn R, Liu L, Wahl E, Coleman H, Cockrell G, Perrien D, Lumpkin CJ, Thrailkill K (2008) Runt-related transcription factor 2 (RUNX2) and RUNX2-related Osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 149:1697\u20131704","journal-title":"Endocrinology"},{"key":"3802_CR15","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.febslet.2010.05.047","volume":"584","author":"S Portal-Nunez","year":"2010","unstructured":"Portal-Nunez S, Lozano D, de Castro LF, de Gortazar AR, Nogues X, Esbrit P (2010) Alterations of the wnt\/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice. FEBS Lett 584:3095\u20133100","journal-title":"FEBS Lett"},{"key":"3802_CR16","first-page":"455","volume":"28","author":"M Hie","year":"2011","unstructured":"Hie M, Iitsuka N, Otsuka T, Tsukamoto I (2011) Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28:455\u2013462","journal-title":"Int J Mol Med"},{"key":"3802_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","volume":"11","author":"A Gaudio","year":"2014","unstructured":"Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE (2014) The relationship between inhibitors of the wnt signalling pathway (sclerostin and dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 11:48\u201352","journal-title":"Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease"},{"key":"3802_CR18","doi-asserted-by":"crossref","first-page":"e111703","DOI":"10.1371\/journal.pone.0111703","volume":"9","author":"A Garcia-Martin","year":"2014","unstructured":"Garcia-Martin A, Reyes-Garcia R, Garcia-Fontana B, Morales-Santana S, Coto-Montes A, Munoz-Garach M, Rozas-Moreno P, Munoz-Torres M (2014) Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PLoS One 9:e111703","journal-title":"PLoS One"},{"key":"3802_CR19","doi-asserted-by":"crossref","unstructured":"Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, Formoso G, Consoli A, Aukrust P, Davi G (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc 3","DOI":"10.1161\/JAHA.114.001000"},{"key":"3802_CR20","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.1210\/jc.2012-3038","volume":"98","author":"TC Register","year":"2013","unstructured":"Register TC, Hruska KA, Divers J et al (2013) Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab 98:E60\u2013E65","journal-title":"J Clin Endocrinol Metab"},{"key":"3802_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/eye.2013.229","volume":"28","author":"F Qiu","year":"2014","unstructured":"Qiu F, He J, Zhou Y, Bai X, Wu G, Wang X, Liu Z, Chen Y, Ma JX, Liu Z (2014) Plasma and vitreous fluid levels of dickkopf-1 in patients with diabetic retinopathy. Eye 28:402\u2013409","journal-title":"Eye"},{"key":"3802_CR22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/pedi.12288","volume":"17","author":"C Tsentidis","year":"2016","unstructured":"Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K (2016) Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density. Pediatr Diabetes 17:289\u2013299","journal-title":"Pediatr Diabetes"},{"key":"3802_CR23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00198-015-3422-5","volume":"27","author":"C Tsentidis","year":"2016","unstructured":"Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K (2016) Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:1631\u20131643","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"3802_CR24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00125-009-1615-1","volume":"53","author":"B Gustafson","year":"2010","unstructured":"Gustafson B, Eliasson B, Smith U (2010) Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor dickkopf-1 in adipocytes: a link with osteogenesis. Diabetologia 53:536\u2013540","journal-title":"Diabetologia"},{"key":"3802_CR25","doi-asserted-by":"crossref","first-page":"460210","DOI":"10.1155\/2013\/460210","volume":"2013","author":"SF Ahmed","year":"2013","unstructured":"Ahmed SF, Fouda N, Abbas AA (2013) Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers. J Osteoporos 2013:460210","journal-title":"J Osteoporos"},{"key":"3802_CR26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2265.2009.03728.x","volume":"72","author":"AD Anastasilakis","year":"2010","unstructured":"Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E (2010) The effect of teriparatide on serum dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol 72:752\u2013757","journal-title":"Clin Endocrinol"},{"key":"3802_CR27","first-page":"725","volume":"94","author":"E Voskaridou","year":"2009","unstructured":"Voskaridou E, Christoulas D, Xirakia C, Varvagiannis K, Boutsikas G, Bilalis A, Kastritis E, Papatheodorou A, Terpos E (2009) Serum dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration Haematologica 94:725\u2013728","journal-title":"Reduction post-zoledronic acid administration Haematologica"},{"key":"3802_CR28","doi-asserted-by":"crossref","first-page":"E546","DOI":"10.1152\/ajpendo.00535.2012","volume":"304","author":"G Brunetti","year":"2013","unstructured":"Brunetti G, Faienza M, Piacente L et al (2013) High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am J Physiol Endocrinol Metab 304:E546\u2013E554","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3802_CR29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00223-009-9303-1","volume":"85","author":"W Mak","year":"2009","unstructured":"Mak W, Shao X, Dunstan C, Seibel M, Zhou H (2009) Biphasic glucocorticoid-dependent regulation of wnt expression and its inhibitors in mature osteoblastic cells. Calcif Tissue Int 85:538\u2013545","journal-title":"Calcif Tissue Int"},{"key":"3802_CR30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2474-11-210","volume":"11","author":"JS Butler","year":"2010","unstructured":"Butler JS, Queally JM, Devitt BM, Murray DW, Doran PP, O\u2019Byrne JM (2010) Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet Disord 11:210","journal-title":"BMC Musculoskelet Disord"},{"key":"3802_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bonekey.2012.101","volume":"1","author":"JL Sottnik","year":"2012","unstructured":"Sottnik JL, Hall CL, Zhang J, Keller ET (2012) Wnt and wnt inhibitors in bone metastasis. BoneKEy reports 1:101","journal-title":"BoneKEy reports"},{"key":"3802_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CGM.S16817","volume":"7","author":"A Hameed","year":"2014","unstructured":"Hameed A, Brady JJ, Dowling P, Clynes M, O\u2019Gorman P (2014) Bone disease in multiple myeloma: pathophysiology and management. Cancer growth and metastasis 7:33\u201342","journal-title":"Cancer growth and metastasis"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3802-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3802-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3802-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T07:58:56Z","timestamp":1531209536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3802-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3802"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3802-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}